Author: Curtò, Diego; Tomatis, Federica; Gastoldi, Sara; Galbusera, Miriam; Noris, Marina; Raimondi, Federico; Lorini, Ferdinando Luca; Falanga, Anna; Marchetti, Marina; Remuzzi, Giuseppe; Ruggenenti, Piero
Title: Case Report: Effects of Anti-SARS-CoV-2 Convalescent Antibodies Obtained With Double Filtration Plasmapheresis Cord-id: aijoil92 Document date: 2021_6_30
ID: aijoil92
Snippet: Passive antibody therapy has been used to treat outbreaks of viral disease, including the ongoing pandemic of severe respiratory acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) or COVID-19. However, the real benefits of the procedure are unclear. We infused a concentrated solution of neutralizing anti-SARS-CoV-2 antibodies obtained from a convalescent donor with a single session of double filtration plasmapheresis (DFPP) into a 56-year-old woman with long history of unremitting, sev
Document: Passive antibody therapy has been used to treat outbreaks of viral disease, including the ongoing pandemic of severe respiratory acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) or COVID-19. However, the real benefits of the procedure are unclear. We infused a concentrated solution of neutralizing anti-SARS-CoV-2 antibodies obtained from a convalescent donor with a single session of double filtration plasmapheresis (DFPP) into a 56-year-old woman with long history of unremitting, severe COVID-19. She was unable to establish an adequate antiviral immune response because of previous chemotherapy, including the infusion of the anti-CD20 monoclonal antibody rituximab, administered to treat a diffuse large B-cell lymphoma. The disease promptly recovered despite evidence of no endogenous anti-SARS-CoV-2 antibody production. The observation that passive antibody therapy might prove particularly effective in immunodepressed COVID-19 patients requires evaluation in prospective randomized controlled trial.
Search related documents:
Co phrase search for related documents- acute increase and low intensity: 1, 2
- acute respiratory syndrome and additional dose: 1, 2, 3, 4, 5
- acute respiratory syndrome and adequate titer: 1
- acute respiratory syndrome and local ethical committee: 1
- acute respiratory syndrome and long term history: 1, 2, 3
- acute respiratory syndrome and low flow nasal cannula: 1
- acute respiratory syndrome and low intensity: 1, 2, 3, 4, 5, 6, 7, 8, 9
- additional dose and low intensity: 1
Co phrase search for related documents, hyperlinks ordered by date